Chantal Mathieu

Research interests

Publications

• Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  Diabetologia · 2022 · https://doi.org/10.1007/s00125-022-05787-2

• Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

  The Lancet Diabetes & Endocrinology · 2022 · https://doi.org/10.1016/s2213-8587(22)00319-9

• Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  Diabetes Care · 2022 · https://doi.org/10.2337/dci22-0034

• Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial

  The Lancet Diabetes & Endocrinology · 2021 · https://doi.org/10.1016/s2213-8587(21)00019-x

• Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  Diabetologia · 2018 · https://doi.org/10.1007/s00125-018-4729-5

• Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

  The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)32261-x

• Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

  The Lancet Diabetes & Endocrinology · 2017 · https://doi.org/10.1016/s2213-8587(17)30308-x

• Steviol glycosides enhance pancreatic beta-cell function and taste sensation by potentiation of TRPM5 channel activity

  Nature Communications · 2017 · https://doi.org/10.1038/ncomms14733

• Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

  The Lancet Diabetes & Endocrinology · 2017 · https://doi.org/10.1016/s2213-8587(17)30308-x

• Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis

  Diabetes · 2016 · https://doi.org/10.2337/db16-0806

• Optimal Vitamin D Status: A Critical Analysis on the Basis of Evidence-Based Medicine

  The Journal of Clinical Endocrinology & Metabolism · 2013 · https://doi.org/10.1210/jc.2013-1195

• ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death

  Autophagy · 2013 · https://doi.org/10.4161/auto.25399

• A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death

  The EMBO Journal · 2012 · https://doi.org/10.1038/emboj.2011.497

• Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice

  Endocrine Reviews · 2008 · https://doi.org/10.1210/er.2008-0004

• Prevalence and Predictors of Sexual Dysfunction in Patients With Type 1 Diabetes

  Diabetes Care · 2003 · https://doi.org/10.2337/diacare.26.2.409

• Sexual Dysfunction in Women With Type 1 Diabetes

  Diabetes Care · 2002 · https://doi.org/10.2337/diacare.25.4.672

• An Overview of Real-Time Quantitative PCR: Applications to Quantify Cytokine Gene Expression

  Methods · 2001 · https://doi.org/10.1006/meth.2001.1261

Current projects

No projects listed.